Mode of Action:

MOXIFLOXIN, in MOXITAK-β EYE/EAR DROPS works as an anti-bacterial agent Floro-Quinolones exert their antibacterial effect by preventing bacterial DNA from unwinding and duplicating.  Moxifloxacin hydrochloride is a synthetic 8-methoxyfluoroquinolone with a broad spectrum anti-bacterial effect on gram positive, gram negative and other anaerobic micro-organism. Well tolerated with minimal ocular side effects and provides increased penetration into ocular tissues and fluids with improved activity against Streptococci and Staphylococci species. It has a moderate to excellent activity against clinically relevant, gram-negative ocular pathogens.

BETAMETHASONE in MOXITAK-β EYE/EAR DROPS is a glucocorticoid and is a potent Anti-Inflammatory which binds with the corticosteroid receptors and alters the protein synthesis thus prevents the leukocyte infiltration at the site of inflammation, interferes in the function of the mediators responsible for the inflammatory response, and suppresses the humoral immune responses and reduction in edema or scar tissue. The anti-inflammatory actions of Betamethasone involve phospholipase A2 inhibitory proteins which control the biosynthesis of potent mediators of inflammation such as prostaglandins and Cyclooxygenase (COX-1 & COX-2).

Bacterial Infection, Inflammation and pain associated with Post Surgery, Lasik and Ocular infections of susceptible strains.

Hypersensitivity towards any of the component in the solution.

Warnings and Precautions:

• Growth of Resistant Organisms with Prolonged Use
• Avoidance of Contact Lens Wear
• if irritations persist, discontinue the use and consult the eye doctor
• Prolonged use may result in glaucoma
• Defects in visual acuity and fields of vision

Adverse Effect:

• Nausea, Diarrhea, Dizziness, blurred vision that does not go away, burning, stinging, or itching of the eyes or eyelids.
• Ocular hyperemia, Ocular pain and Ocular pruritus